These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 6198394

  • 21. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG, Hoofnagle JH, Minuk GY, Purcell RH, Gerin JL.
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [Abstract] [Full Text] [Related]

  • 22. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y, Nagler A, Zeira E, Adler R, Slavin S, Shouval D.
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [Abstract] [Full Text] [Related]

  • 23. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
    Sylvan SP, Hellström UB, Lundbergh PR.
    Clin Exp Immunol; 1985 Nov; 62(2):288-95. PubMed ID: 3878745
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T, Jilg W.
    Vaccine; 2006 Jan 30; 24(5):572-7. PubMed ID: 16171909
    [Abstract] [Full Text] [Related]

  • 25. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.
    Cupps TR, Tibbles J, Hurni WM, Miller WJ, Ellis RW, Milich D, Wetter N.
    J Immunol; 1993 Sep 15; 151(6):3353-60. PubMed ID: 7690803
    [Abstract] [Full Text] [Related]

  • 26. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D, Lanier G, Yuan ZH, Wen YM, Howard CR, Ahmed R.
    J Med Virol; 2008 Feb 15; 80(2):225-32. PubMed ID: 18098130
    [Abstract] [Full Text] [Related]

  • 27. Comparative analysis of HLA restriction and cytokine production in hepatitis B surface antigen-specific T cells from low- and high-antibody responders in vaccinated humans.
    Wataya M, Sano T, Kamikawaji N, Tana T, Yamamoto K, Sasazuki T.
    J Hum Genet; 2001 Feb 15; 46(4):197-206. PubMed ID: 11322660
    [Abstract] [Full Text] [Related]

  • 28. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg.
    Milich DR, McLachlan A, Chisari FV, Kent SB, Thorton GB.
    J Immunol; 1986 Jul 01; 137(1):315-22. PubMed ID: 2423607
    [Abstract] [Full Text] [Related]

  • 29. Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma.
    Celis E, Miller RW, Wiktor TJ, Dietzschold B, Koprowski H.
    J Immunol; 1986 Jan 01; 136(2):692-7. PubMed ID: 2416820
    [Abstract] [Full Text] [Related]

  • 30. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T, Günther M, Bienzle U, Neuhaus R, Jilg W.
    Liver Transpl; 2007 Mar 01; 13(3):434-42. PubMed ID: 17318860
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
    Schiött A, Larsson K, Manniche S, Kalliomäki S, Heydenreich AV, Dalsgaard K, Kirkby N.
    Int J Pharm; 2011 Jul 29; 414(1-2):312-20. PubMed ID: 21601626
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I, Willems A, Gijbels Y, Leroux-Roels G.
    J Virol; 2006 Apr 29; 80(7):3506-14. PubMed ID: 16537618
    [Abstract] [Full Text] [Related]

  • 35. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL, Murray K.
    J Med Virol; 1997 Mar 29; 51(3):159-66. PubMed ID: 9139078
    [Abstract] [Full Text] [Related]

  • 36. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
    Yamamoto H, Satoh T, Kiyohara T, Totsuka A, Moritsugu Y.
    Biologicals; 1997 Dec 29; 25(4):373-80. PubMed ID: 9467033
    [Abstract] [Full Text] [Related]

  • 37. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia.
    Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R.
    Hepatology; 1997 Dec 29; 26(6):1658-66. PubMed ID: 9398013
    [Abstract] [Full Text] [Related]

  • 38. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S, Guidotti LG, Ando K, Schlicht HJ, Chisari FV.
    J Immunol; 1995 Mar 01; 154(5):2504-15. PubMed ID: 7868916
    [Abstract] [Full Text] [Related]

  • 39. T-cell responses to hepatitis B surface antigen in lung transplant recipients.
    Hayney MS, Wiegert NA, Pelsue FL, Fohl RM, Jankowska-Gan E, Love RB, Burlingham WJ.
    Pharmacotherapy; 2007 Sep 01; 27(9):1248-52. PubMed ID: 17723078
    [Abstract] [Full Text] [Related]

  • 40. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.
    Cancer; 2002 Jan 15; 94(2):406-14. PubMed ID: 11900226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.